Market Whales and Their Recent Bets on REGN Options
Portfolio Pulse from Benzinga Insights
Recent options trading activity on Regeneron Pharmaceuticals (NASDAQ:REGN) shows a predominantly bearish sentiment among large investors, with 88% of trades being puts. This unusual activity suggests potential upcoming changes in the stock's price. Analysts have mixed ratings, with price targets ranging from $1077 to $1300.
October 03, 2024 | 6:34 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Regeneron Pharmaceuticals has seen unusual options activity with a bearish sentiment, as 88% of recent trades are puts. This suggests potential downward pressure on the stock. Analysts have mixed ratings, with price targets ranging from $1077 to $1300.
The significant bearish sentiment in options trading, with 88% of trades being puts, indicates that large investors expect the stock price to decline. This is further supported by mixed analyst ratings, with some downgrades and a wide range of price targets.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100